Zolbetuximab Approval Paves Way for Precision Medicine in Gastric and GEJ Adenocarcinoma OncLive Nawigacja wpisu Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference – Yahoo Finance Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference – Business Wire
